bioRxiv
NRF2-dependent metabolic reprogramming is required for tumor recurrence following oncogene inhibition
Publication
, Preprint
Fox, D; Lupo, R; Noteware, L; Newcomb, R; Liu, J; Locasale, J; Hirschey, M; Alvarez, J
2019
Duke Scholars
Citation
APA
Chicago
ICMJE
MLA
NLM
Fox, D., Lupo, R., Noteware, L., Newcomb, R., Liu, J., Locasale, J., … Alvarez, J. (2019). NRF2-dependent metabolic reprogramming is required for tumor recurrence following oncogene inhibition. bioRxiv. https://doi.org/10.1101/513994
Fox, Douglas, Ryan Lupo, Laura Noteware, Rachel Newcomb, Juan Liu, Jason Locasale, Matthew Hirschey, and James Alvarez. “NRF2-dependent metabolic reprogramming is required for tumor recurrence following oncogene inhibition.” BioRxiv, 2019. https://doi.org/10.1101/513994.
Fox D, Lupo R, Noteware L, Newcomb R, Liu J, Locasale J, et al. NRF2-dependent metabolic reprogramming is required for tumor recurrence following oncogene inhibition. bioRxiv. 2019.
Fox, Douglas, et al. “NRF2-dependent metabolic reprogramming is required for tumor recurrence following oncogene inhibition.” BioRxiv, 2019. Epmc, doi:10.1101/513994.
Fox D, Lupo R, Noteware L, Newcomb R, Liu J, Locasale J, Hirschey M, Alvarez J. NRF2-dependent metabolic reprogramming is required for tumor recurrence following oncogene inhibition. bioRxiv. 2019.